Stem cells used to produce blood platelets

SAN DIEGO Sun Dec 11, 2011 11:13am IST

Aastrom Biosciences production assistant Mary Cheeramvelil works at 'priming' cell cassettes for incubation in the clean room laboratory at their headquarters in Ann Arbor, Michigan November 29, 2011. REUTERS/Rebecca Cook

Aastrom Biosciences production assistant Mary Cheeramvelil works at 'priming' cell cassettes for incubation in the clean room laboratory at their headquarters in Ann Arbor, Michigan November 29, 2011.

Credit: Reuters/Rebecca Cook

Related Topics

Rajalakshmi (C), 28, smiles after winning the Miss Wheelchair India beauty pageant in Mumbai November 26, 2014. REUTERS/Danish Siddiqui

Miss Wheelchair India

Seven women from across India participated in the country's second wheelchair beauty pageant, which aims to open doors for the wheelchair-bound in modelling, film and television, according to organisers  Slideshow 

SAN DIEGO (Reuters) - Scientists have for the first time created blood platelet cells by reprogramming stem cells derived from adult cells, offering the potential for a renewable supply of the fragile blood component.

Researchers at the Center for iPS Cell Research and Application at Kyoto University in Japan presented data at a meeting of the American Society of Hematology showing they were able to create the cells in the laboratory and confirm they had the same life span as normal human platelets when infused in mice.

"The next step will be to conduct a trial to determine whether our platelets can function in the human body," said Dr. Koji Eto, professor at the Kyoto center and senior author of the study.

Induced pluripotent stem cells, or iPS cells, are produced by manipulating ordinary human skin or blood cells back to a state in which they are able to differentiate into a number of different cell types.

When they were first discovered in 2006, iPS cells looked like a perfect solution to the ethical debate over the use of embryonic stem cells, but the process of producing non-mutated cells has proved challenging.

The limitation in using stem cells to produce platelets has been the ability to find a method that creates a large number of high-quality, functional platelets.

The Japanese researchers set out to create an immortalized cell line with a large number of high-quality megakaryocytes -- precursor cells that develop into platelets -- from stem cells that can be grown indefinitely and differentiate into a variety of cell types in the body.

They were able to produce a cell line that turned off certain genes to generate functional platelets. They then tested the cultured platelets by infusing them into immunodeficient mouse models and confirmed that they had the same life span as human platelets infused in mice.

"This has the potential of marching us forward to a day when we might to able to eliminate blood platelet shortages," said Dr. Charles Abrams, ASH secretary and associate chief of hematology/oncology at the University of Pennsylvania in Philadelphia.

In normal clotting, platelets stick together and form a plug at the site of an injured blood vessel, allowing the injured site to heal.

FILED UNDER:

SAARC Summit

REUTERS SHOWCASE

Ferguson Riots

Ferguson Riots

National Guard, police curb Ferguson unrest as protests swell across U.S.  Full Article 

Hong Kong Protests

Hong Kong Protests

Hong Kong riot police clear protest site, arrest student leaders.  Full Article 

Special Report

Special Report

Putin's allies channelled billions to Ukraine oligarch.  Full Article 

Polls 2016

Polls 2016

Romney tops Republican poll for '16; ahead of Clinton in election.  Full Article 

Syrian Crisis

Syrian Crisis

Russia vows support for Syria's Assad to combat "terrorism".  Full Article 

Tackling Jihadis

Tackling Jihadis

INSIGHT - Secular France moves to confront jihadism after slow start.  Full Article 

Award Backlash

Award Backlash

Save the Children under pressure, 100,000 oppose award for Tony Blair.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage